The U.S. Commodity Futures Trading Commission (CFTC) asks a judge to dismiss a lawsuit filed by CME Group challenging the regulator’s approval of crypto perpetual futures. In filings described by multiple outlets, the CFTC argues the case is “much ado about nothing,” asserting that the relevant regulatory order does not block CME from listing similar products.
The CFTC says CME lacks legal standing, particularly on claims that it faces competitive injury. According to the coverage, the CFTC argues CME has not shown concrete, financial harm needed for the lawsuit to proceed. Outlets also report the regulator’s position that the order allows any designated contract market, including CME, to list perpetual futures, undermining CME’s basis for bringing the case.
CME’s lawsuit is framed by the CFTC as a challenge that does not meet the court’s requirements for standing and injury. While outlets agree on the CFTC’s request and the central arguments—lack of standing and availability of listing pathways—sources differ mainly in how they emphasize the standing issue versus the broader “nothing-blocking” interpretation of the approval order.
